ANTIVIRAL TREATMENT REDUCES HEPATOCELLULAR CARCINOMA RISK IN NON-CIRRHOTIC, HBEAG-NEGATIVE CHRONIC HEPATITIS B WITH HIGH VIRAL LOAD

被引:0
|
作者
Choi, Won-Mook [1 ]
Kim, Gi-Ae [2 ]
Choi, Gwang Hyeon [1 ,3 ,4 ]
Choi, Jonggi
Lee, Yun Bin [3 ,4 ]
Sinn, Dong Hyun
Lim, Young-Suk [1 ,5 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Liver Ctr, Seoul, South Korea
[2] Kyung Hee Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Med Ctr, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1137
引用
收藏
页码:S263 / S264
页数:2
相关论文
共 50 条
  • [1] Impact of baseline viral load on hepatocellular carcinoma risk during antiviral treatment in non-cirrhotic patients with HBeAg-positive chronic hepatitis B
    Choi, Won-Mook
    Kim, Gi-Ae
    Choi, Jonggi
    Han, Seungbong
    Lim, Young-Suk
    JOURNAL OF HEPATOLOGY, 2022, 77 : S833 - S834
  • [2] Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study
    Papatheodoridi, Margarita
    Su, Tung-Hung
    Hadziyannis, Emilia
    Liao, Chun-Hsun
    Orfanidou, Afroditi
    Yang, Hung-Chi
    Zachou, Kalliopi
    Liu, Chun-Jen
    Kourikou, Anastasia
    Gatselis, Nikolaos
    Manolakopoulos, Spilios
    Dalekos, George
    Kao, Jia-Horng
    Hadziyannis, Stephanos
    Papatheodoridis, George, V
    LIVER INTERNATIONAL, 2022, 42 (03) : 541 - 550
  • [3] Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation
    Huang, Rui
    Wang, Jian
    Yan, Xiaomin
    Xia, Juan
    Wu, Chao
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (05) : 618 - 619
  • [4] TREATMENT DISCONTINUATION IN HBEAG-NEGATIVE CHRONIC HEPATIT B IS A VIABLE OPTION IN NON-CIRRHOTIC GENOTYPE D CHRONIC HEPATITIS B PATIENTS
    Sah, Fatma Tugce
    Keskin, Onur
    Yurdcu, Esra
    Yilmaz, Yusuf
    Karakaya, Muhammet Fatih
    Kartal, Aysun
    Bozdayi, Mithat
    Idilman, Ramazan
    Yurdaydin, Cihan
    HEPATOLOGY, 2019, 70 : 305A - 306A
  • [5] Significance of serum HBV RNA in non-cirrhotic HBeAg-negative chronic hepatitis B patients who discontinue effective antiviral therapy
    Papatheodoridi, Margarita
    Papachristou, Eleni
    Moschidis, Zissis
    Hadziyannis, Emilia
    Rigopoulou, Eirini
    Zachou, Kalliopi
    Villeret, Francois
    Magiorkinis, Gkikas
    Lyberopoulou, Aggeliki
    Gatselis, Nikolaos
    Vlachogiannakos, Ioannis
    Manolakopoulos, Spilios
    Dalekos, George N.
    Zoulim, Fabien
    Paraskevis, Dimitrios
    Papatheodoridis, George, V
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (11) : 948 - 957
  • [6] Treatment of HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Papatheodoridis, GV
    Vassilopoulos, D
    SEMINARS IN LIVER DISEASE, 2003, 23 (01) : 81 - 88
  • [7] Association of Hepatocellular Carcinoma Risk with Baseline Viral Load in HBeAg-positive Chronic Hepatitis B Patients under Antiviral Treatment
    Lee, Minjong
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2022, 80 (03): : 161 - 162
  • [8] RISK OF HEPATOCELLULAR CANCER AND DEATH/TRANSPLANT BETWEEN INACTIVE HEPATITIS B AND HBEAG-NEGATIVE CHRONIC HEPATITIS B WITH ANTIVIRAL AGENTS
    Choi, Gwang Hyeon
    Kim, Gi-Ae
    Choi, Jonggi
    Han, Seungbong
    Lim, Young-Suk
    GUT, 2018, 67 : A104 - A105
  • [9] Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Authors' reply
    Choi, Gwang Hyeon
    Lim, Young-Suk
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (05) : 619 - 620
  • [10] HEPATOCELLULAR CARCINOMA RISK REDUCTION ASSOCIATED WITH ANTIVIRAL TREATMENT IN NON-CIRRHOTIC CHRONIC HEPATITIS B PATIENTS: A COMPARATIVE META-ANALYSIS
    Stead, Alice
    Mohanty, Arpan
    Telep, Laura
    Singer, Amanda
    Curteis, Tristan
    Jafry, Zarena
    Zolotor, Anna
    Frenette, Catherine
    Hammond, Kyle
    Khoshabafard, Dona
    McQuaid, Thomas
    Kelley, Robin
    HEPATOLOGY, 2024, 80 : S180 - S181